Candida dubliniensis

If vaginal symptoms keep returning after treatment, identifying the yeast can help explain what's happening. Most vaginal yeast infections involve Candida albicans. Candida dubliniensis is a close relative that occasionally appears in vaginal samples and can be mistaken for it. Finding this species doesn't automatically mean you have a resistant infection, but the vaginal data point in both directions. Three genetically confirmed vaginal isolates in one Iranian study were susceptible to commonly used antifungals, while a small Ghanaian study classified all four of its isolates as fluconazole-resistant. Shokoohi et al. Aboagye et al.

This result reports C. dubliniensis in a vaginal swab, using the unit x10^5 CFU/g. The available test information doesn't specify the measurement method. Identifying Candida species has an established role in evaluating complicated vaginal infections, but using this particular quantitative result to diagnose disease, predict recurrence, or guide treatment remains exploratory. The cited studies don't establish a disease threshold or treatment target for this measurement. CDC guidance

Why Identification Can Be Difficult

C. dubliniensis and C. albicans can both form short outgrowths called germ tubes and thick-walled spores. These shared features make a quick visual identification unreliable. Growth at higher temperatures can provide a clue, but it cannot consistently separate the species. Some C. dubliniensis strains grow at temperatures once thought to rule it out. Pincus et al.

Confirmation can use species-specific genetic methods or a validated instrument that identifies microbes from their protein patterns. These are examples of identification methods, not a description of the unspecified method used for this test. Shokoohi et al. Hof et al.

Older identification systems sometimes confused the two species. In a 2003 Singapore study, the API 20C AUX system labeled 12 of 20 C. dubliniensis isolates as C. albicans. Those isolates came from several body sites, so this wasn't a vaginal-test accuracy estimate. It also doesn't describe the performance of every current laboratory system. Yang et al.

Some molecular vaginitis tests deliberately combine several species into one result. The Aptima Candida/Trichomonas assay, for example, includes C. dubliniensis in a Candida group with C. albicans and two other species. A positive group result detects a member of that group without identifying which one. Grouping the species is different from failing to detect them. Schwebke et al.

How Often It Appears in Vaginal Samples

Published studies generally find C. dubliniensis infrequently, but their percentages use different denominators. Some count all participants, some count positive yeast cultures, and others recheck only isolates initially identified as C. albicans.

These pregnancy studies relied on growth characteristics and biochemical identification rather than genetic confirmation. Their findings need to be interpreted with the identification difficulties in mind. None establishes how a particular vaginal quantity relates to symptoms or treatment response.

Studies using genetic identification also show that prevalence varies. The Singapore survey found five C. dubliniensis isolates among 413 vaginal yeast isolates. A Chinese study found none when it rechecked 1,014 vaginal isolates previously labeled C. albicans, and an Iranian study found none among 100 vaginal isolates from the C. albicans species complex. These selected samples don't provide a single prevalence estimate for everyone. Yang et al. Shan et al. Farahyar et al.

The Species Name Doesn't Establish Drug Resistance

In the Ghana study, all four isolates identified as C. dubliniensis were classified as fluconazole-resistant by the study's laboratory testing. That is a small local sample, and identification wasn't genetically confirmed. It cannot establish that vaginal C. dubliniensis is usually resistant. Aboagye et al.

A separate Iranian study genetically confirmed three vaginal C. dubliniensis isolates and found them susceptible to fluconazole and clotrimazole. The broader view that this species is usually azole-susceptible rests mainly on oral isolates and laboratory testing, not vaginal samples. Laboratory work has also shown that C. dubliniensis can readily develop stable fluconazole resistance after azole exposure. Together, these are reasons to avoid predicting an individual strain's response from its name alone. Shokoohi et al.

Susceptibility testing examines whether an antifungal inhibits a cultured yeast under laboratory conditions. It can help with drug selection when symptoms persist, but it doesn't determine the dose you should take or guarantee that treatment will work. Symptoms can also have another cause. IDSA guidance

Living There Versus Causing Symptoms

Candida can live in the vagina without causing illness. Itching, burning, soreness, and discharge can occur with a yeast infection, but these symptoms also occur with other conditions. A positive swab therefore needs to fit the symptoms and examination findings before the yeast is treated as the cause. IDSA guidance

The surrounding bacteria may influence yeast colonization, though the evidence isn't specific to this species. An observational study of 255 nonpregnant women measured vaginal Candida as a group. Women whose vaginal bacteria were dominated by Lactobacillus iners had roughly three times the odds of Candida detection compared with women dominated by Lactobacillus crispatus. Separate laboratory experiments in that study found stronger inhibition of C. albicans growth by L. crispatus cultures. Those experiments didn't establish an effect on vaginal C. dubliniensis in people. Tortelli et al.

When Results Can Be Misleading

• Presence without infection: detection can reflect colonization. The number alone doesn't establish that this yeast is causing your symptoms.
• Unspecified measurement method: CFU stands for colony-forming units. The reported unit is scaled to hundreds of thousands per gram, but the unit label alone doesn't establish whether the laboratory directly grew and counted living organisms. The method and its validation need to be known before making that assumption.
• Different tests answer different questions: a pooled Candida result, a species identification, and a quantitative abundance result aren't interchangeable. Numbers obtained by different methods or laboratories shouldn't be treated as directly comparable.
• Recent treatment and collection conditions: antifungals can reduce recoverable yeast, and vaginal products or collection problems can affect testing. Preparation and collection instructions belong to the specific laboratory and kit.
• Symptoms with another cause: bacterial vaginosis, trichomoniasis, irritation, and other conditions can overlap with symptoms attributed to yeast. Detecting C. dubliniensis doesn't exclude them. ACOG guidance

What Serial Results Can Show

The cited vaginal studies don't establish how much a change in this test's reported quantity matters. A lower result hasn't been validated as proof of cure, and detecting the same species again doesn't establish that the original strain persisted. Findings about persistent oral strains cannot supply a vaginal monitoring schedule.